NCT04068194 2026-04-13
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Coordinación de Investigación en Salud, Mexico
Consorci Sanitari de Terrassa
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
University of Utah